Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep vs standard neuromuscular blockade with low vs standard insufflation pressure in laparoscopic cholecystectomy
2012-001886-33Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2012
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of rocuronium and Sugammadex (4 arms), sponsored by Merck & Co. Started Aug 2012; status: completed.
02
Drugs
rocuroniumSugammadex
Beyond the preview
Go deeper on 2012-001886-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001886-33.